N of CXCR4-using variants needs to be improved. Next-generation sequencing plus accurate genotypic algorithms for predicting HIV-1 tropism will eventually provide sensitive methods for managing the administration of CCR5 antagonists and for pathophysiological studies.Materials and MethodsSamples and nucleic acid extraction.Plasma samples were obtained from 52 HIV-1-infected patients followed at th